PAULA ZIMBREAN: Open Payments
NPI 1477542249 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,250 in 3 payments from 1 company in 2025. Trend: 2023 $14,386 · 2024 $9,250 · 2025 $7,250
Consulting: $7,250
| Company | Payments | Amount |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 3 | $7,250 |
Industry payments across CT — which companies pay providers there.
